Loading organizations...
Loading organizations...
Clinical-stage immuno-oncology company developing dual-function biologics.
Amphivena Therapeutics has raised $62.0M across 1 funding round.
Amphivena Therapeutics has raised $62.0M in total across 1 funding round.
Amphivena Therapeutics has raised $62.0M in total across 1 funding round.
Amphivena Therapeutics's investors include NanoDimension, Qiming Venture Partners USA, Franklin Berger, AJU IB Investment, Industrial Investors, Kaitai Capital, Korys Merieux, MPM Capital, Nawton Limited, Tekla Capital Management.
Amphivena Therapeutics has raised $62.0M across 1 funding round. Most recently, it raised $62.0M Series C in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 24, 2019 | $62.0M Series C | NanoDimension, Qiming Venture Partners USA | Franklin Berger, AJU IB Investment, Industrial Investors, Kaitai Capital, Korys Merieux, MPM Capital, Nawton Limited, Tekla Capital Management |